On April 23, we suggested investors take a bullish posture on NVO, the maker of Ozempic (a popular diabetes therapy) and Wegovy (the popular weight loss drug). This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post Apple Inc: AAPLNext PostDollar General: DG You Might Also Like Microstrategy Inc: MSTR November 25, 2023 Options Expiration | 21-August-2021 August 19, 2020 Goldman Sachs (GS): Buy the Dip? January 18, 2022
You Might Also Like Microstrategy Inc: MSTR November 25, 2023 Options Expiration | 21-August-2021 August 19, 2020 Goldman Sachs (GS): Buy the Dip? January 18, 2022
